Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Maravai LifeSciences Holdings Inc MRVI

Technology Scientific & Technical Instruments
Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enable the development of drug therapies, diagnostics and vaccines and to support research on human diseases. Its companies provide products and services in the fields of nucleic acid synthesis and biologics safety testing to various biopharmaceutical, vaccine, diagnostics, and cell and gene... see more

Recent & Breaking News (NDAQ:MRVI)

Maravai LifeSciences Announces November 2024 Investor Conference Schedule

GlobeNewswire 9 hours ago

Maravai LifeSciences Reports Third Quarter 2024 Financial Results

GlobeNewswire 5 days ago

Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024

GlobeNewswire October 15, 2024

TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe(TM) RNA Polymerase

Business Wire September 24, 2024

Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes(TM) Host Cell DNA Quantification Kits

Business Wire August 28, 2024

Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule

GlobeNewswire August 12, 2024

Maravai LifeSciences Reports Second Quarter 2024 Financial Results

GlobeNewswire August 7, 2024

Maravai LifeSciences Appoints Trey Martin to Board of Directors

GlobeNewswire July 29, 2024

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024

GlobeNewswire July 10, 2024

Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report

GlobeNewswire July 2, 2024

TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center

Business Wire May 13, 2024

Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule

GlobeNewswire May 9, 2024

Maravai LifeSciences Reports First Quarter 2024 Financial Results

GlobeNewswire May 8, 2024

TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology

Business Wire April 30, 2024

TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production

Business Wire April 18, 2024

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024

GlobeNewswire April 10, 2024

Maravai LifeSciences Announces March 2024 Investor Conference Schedule

GlobeNewswire March 12, 2024

Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire February 22, 2024

TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada

Business Wire February 21, 2024

Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing

GlobeNewswire February 13, 2024